Cannabinoids: potential anticancer agents

  title={Cannabinoids: potential anticancer agents},
  author={Manuel Guzm{\'a}n},
  journal={Nature Reviews Cancer},
  • M. Guzmán
  • Published 1 October 2003
  • Biology
  • Nature Reviews Cancer
Cannabinoids — the active components of Cannabis sativa and their derivatives — exert palliative effects in cancer patients by preventing nausea, vomiting and pain and by stimulating appetite. In addition, these compounds have been shown to inhibit the growth of tumour cells in culture and animal models by modulating key cell-signalling pathways. Cannabinoids are usually well tolerated, and do not produce the generalized toxic effects of conventional chemotherapies. So, could cannabinoids be… 
Anticancer mechanisms of cannabinoids.
The current understanding of cannabinoids as antitumour agents is discussed, focusing on recent discoveries about their molecular mechanisms of action, including resistance mechanisms and opportunities for their use in combination therapy.
Cannabinoids for cancer treatment: progress and promise.
Recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy is reviewed.
Cannabinoids in the treatment of cancer.
Towards the use of cannabinoids as antitumour agents
The current understanding of cannabinoids as antitumour agents is discussed, focusing on recent insights into the molecular mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches.
Cannabinoids and cancer: pros and cons of an antitumour strategy
This article will review the principal molecular pathways modulated by cannabinoids on cancer and summarize pros and cons evidence on the possible future use of endocannabinoid‐based drugs in cancer therapy.
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy‐induced Adverse Effects: An Exploratory Review
This exploratory review scrutinizes the potential of cannabinoids to counteract chemotherapy‐induced side effects and some novel and yet important pharmacological aspects of cannabinoids such as antitumoral effects will be discussed.
Cannabinoids and Breast Cancer
the role of cannabinoids in the treatment of children with cancer
Cannabinoids are a heterogeneous group of compounds that exhibit activity by binding to specific receptors called cannabinoid receptors, and the synthetic analogs of both groups are called synthetic cannabinoids.
The use of cannabinoids as anticancer agents
Cannabinoids: potential antitumoral agents?
The fair safety profile of THC, together with its possible growth-inhibiting action on tumor cells, may set the basis for future trials aimed at evaluating the potential antitumoral activity of cannabinoids.


Established and potential therapeutic applications of cannabinoids in oncology
The use of cannabinoids should be continued in the areas indicated, and further studies are needed to evaluate other potential uses in clinical oncology.
Cannabinoids: a real prospect for pain relief?
Inhibition of tumor angiogenesis by cannabinoids
It is shown that local administration of a nonpsychoactive cannabinoid to mice inhibits angiogenesis of malignant gliomas as determined by immunohistochemical analyses and vascular permeability assays.
Cannabidiol: An Overview of Some Pharmacological Aspects
The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD.
Pharmacological and biochemical interactions between opioids and cannabinoids.
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
It is shown that intratumoral administration of Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist WIN-55,212-2 induced a considerable regression of malignant gliomas in Wistar rats and in mice deficient in recombination activating gene 2.
Therapeutic Potential of Cannabinoids in CNS Disease
Recent advances in understanding of the endocannabinoid system are highlighted and CNS disorders that may benefit from the therapeutic effects of cannabinoid treatment are indicated.
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
The administration of single oral doses of delta‐9‐tetrahydrocannabinol (THC) to patients with cancer pain demonstrated a mild analgesic effect. At a dose of 20 mg, however, THC induced side effects